TOP$ — The Optimal PDL $olution
TOP$ is the multi-state Medicaid pharmaceutical purchasing pool administered by Magellan Rx Management.
Magellan Rx has been very successful in managing PDLs and negotiating rebates for over 7 million lives. The company’s proven expertise in improving the clinical and financial performance of clients will augment the purchasing power of multiple states acting in concert as participants in TOP$ The Optimal PDL $olution.
TOP$ Forms and Resources
Upcoming Products for Review:
- New Drug Review List (TBD)
- Class & Product Review List (November 2023)
- Single Product Review List (November 2023)
Request for Offers:
- E-mail sent on July 25, 2023
The Offer Form provides the mechanism for you to submit Supplemental Rebate offers.
Line Extension Form
The Line Extension Form provides the mechanism for your company to submit line extensions for the Supplemental Rebate program.
- Maryland Department of Health
- Pharmacy Program’s PDL and Pharmacy and Therapeutics Committee
- Preferred Drug List (Effective 7/1/2023)
- Preferred Drug List Implementation Schedule
November 2nd, 2023 at 09:00 AM Eastern Time (US and Canada)
Virtual (Zoom Webinar)
In order to attend the meeting, you must register for the webinar using the following link: https://magellanhealth.zoom.us/webinar/register/WN_r6ryQuqfSJe9oOKRgBZQBw
P&T Meeting Public Testimony Request Form
In order to speak at the meeting, the Public Testimony Registration Form must be submitted to request testimony time at the upcoming P&T meeting.
Registration for Public Testimony Begins: September 18th, 2023
Registration for Public Testimony Ends: October 20th, 2023
*Please note that Public Testimony spot(s) is/are not guaranteed even after registering due to random selection and availability.
Please refer to the “Guidelines for Public Testimony” published here: https://health.maryland.gov/mmcp/pap/pages/Public-Meeting-Announcement-and-Procedures-for-Public-Testimony.aspx
Provider Synergies, LLC is a subsidiary of Magellan Medicaid Administration, Inc., which is part of Magellan Rx Management, LLC